Liu et al. found that lncRNA ROPM was upregulated in breast cancer patients and targeted PLA2G16 to govern breast cancer stem cell properties, resulting in a positive correlation with malignant grade/stage and poor prognosis [17]. Here, PLAAT3 is linked to breast carcinoma.